Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition characterized by complex interactions among genetic, environmental, and biological factors. Increasing evidence suggests that immune system processes intersect with neurodevelopment in ways that may influence brain maturation, synaptic organization, and large-scale network function. However, existing literature is often fragmented across molecular, cellular, and systems levels, limiting the development of a coherent interpretive framework. In this review, we propose a developmental neuroimmune cascade model of ASD, in which early-life immune perturbations, arising from prenatal or perinatal factors, may interact with genetic susceptibility to influence cytokine signaling, microglial function, blood-brain barrier dynamics, and gut-immune communication. These processes may, in turn, affect synaptic pruning, excitatory-inhibitory balance, and the maturation of neural circuits, contributing to alterations in large-scale brain networks implicated in sensory processing, interoception, and social cognition. We synthesize evidence from observational human studies, postmortem analyses, and experimental animal models to examine how immune-related mechanisms may contribute to neurodevelopmental trajectories associated with ASD, while explicitly distinguishing associative findings from mechanistic inference. Particular attention is given to the role of distributed network vulnerability, including, but not limited to, insula-centered systems that integrate internal bodily states with affective and cognitive processing. Finally, we consider implications for biomarker development and stratified intervention approaches, emphasizing the importance of developmental timing, biological heterogeneity, and cautious interpretation of translational potential. Rather than positioning immune dysfunction as a singular cause of ASD, this model conceptualizes neuroimmune processes as modulators of developmental trajectories, offering a structured basis for future research linking immune signaling to circuit-level and behavioral outcomes.
Leisman et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: